Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from uncontrolled studies and small, randomized trials.
In this randomized, controlled, open-label platform trial comparing a range of possible treatments with usual care in patients hospitalized with Covid-19, we randomly assigned 1561 patients to receive hydro...
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher copy:
- Copyright holder:
- Massachusetts Medical Society
- Rights statement:
- Copyright © 2020 Massachusetts Medical Society. All rights reserved.
Effect of hydroxychloroquine in hospitalized patients with COVID-19
If you are the owner of this record, you can report an update to it here: Report update to this record